Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid to reduce bleeding during acute burn surgical debridement
IRCT20240301061135N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in burn injury and Not applicable, sponsored by Iran University of Medical Sciences. Primary endpoint: Intraoperative bleeding volume. Started Apr 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
burn injuryNot applicable
Beyond the preview
Go deeper on IRCT20240301061135N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240301061135N1.